Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and purpose: In various models vagus nerve activation has been shown to ameliorate intestinal inflammation, via nicotinic acetylcholine receptors (nAChRs) expressed on immune cells. As the α7 nAChR has been put forward to mediate this effect, we studied the effect of nicotine and two selective α7 nAChR agonists (AR‐R17779, (‐)‐spiro[1‐azabicyclo[2.2.2] octane‐3,5′‐oxazolidin‐2′‐one and GSK1345038A) on disease severity in two mouse models of experimental colitis. Experimental approach: Colitis was induced by administration of 1.5% dextran sodium sulphate (DSS) in drinking water or 2 mg 2,4,6‐trinitrobenzene sulphonic acid (TNBS) intrarectally. Nicotine (0.25 and 2.50 µmol·kg−1), AR‐R17779 (0.6–30 µmol·kg−1) or GSK1345038A (6–120 µmol·kg−1) was administered daily by i.p. injection. After 7 (DSS) or 5 (TNBS) days clinical parameters and colonic inflammation were scored. Key results: Nicotine and both α7 nAChR agonists reduced the activation of NF‐κB and pro‐inflammatory cytokines in whole blood and macrophage cultures. In DSS colitis, nicotine treatment reduced colonic cytokine production, but failed to reduce disease parameters. Reciprocally, treatment with AR‐R17779 or GSK1345038A worsened disease and led to increased colonic pro‐inflammatory cytokine levels in DSS colitis. The highest doses of GSK1345038A (120 µmol·kg−1) and AR‐R17779 (30 µmol·kg−1) ameliorated clinical parameters, without affecting colonic inflammation. Neither agonist ameliorated TNBS‐induced colitis. Conclusions and implications: Although nicotine reduced cytokine responses in vitro, both selective α7 nAChR agonists worsened the effects of DSS‐induced colitis or were ineffective in those of TNBS‐induced colitis. Our data indicate the need for caution in evaluating α7 nAChR as a drug target in colitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., et al. (2004) · Nature Medicine · doi:10.1038/nm1124 · Cited by 1,170 · cited 4×
“The cellular mechanisms that induce nicotinic inhibition of macrophage activation involve the activation of antiinflammatory Stat3/Socs3 signalling pathways (de Jonge et al., 2005) and inhibition of NF-kB signalling (Wang et al., 2004).”
Influentialde Jonge, W. J., van der Zanden, E. P., The, F. O., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H.-R., Uematsu, S., Akira, S., van den Wijngaard, R. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1229 · Cited by 1,074
Self-citationGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · cited 1×
“However, in mice, a higher dose would result in adverse effects because of activation of a broad range of receptors both peripherally and centrally (Matta et al., 2007).”
BackgroundTransdermal Nicotine for Active Ulcerative Colitis
Pullan, R. D., Rhodes, J., Ganesh, S., Mani, V., Morris, J. S., Williams, G. T., Newcombe, R. G., Russell, M., Feyerabend, C., Thomas, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301202 · Cited by 505 · cited 2×
“Ulcerative colitis patients with a history of smoking usually acquire their disease after they have stopped smoking (Pullan et al., 1994; Thomas et al., 1995; Ingram et al., 2004).”
BackgroundProgress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1
WANG, R., YAN, H., & TANG, X.-C. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00255.x · Cited by 470
Cited by
Vagus nerve stimulation: from epilepsy to the cholinergic anti‐inflammatory pathway
Bonaz, B., Picq, C., Sinniger, V., Mayol, J. F., & Clarençon, D. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12076 · Cited by 309
Cholinergic modulation of the immune system presents new approaches for treating inflammation
Hoover, D. B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.002 · Cited by 300
The vagal innervation of the gut and immune homeostasis
Matteoli, G., & Boeckxstaens, G. E. (2013) · Gut · doi:10.1136/gutjnl-2012-302550 · Cited by 276
Self-citationSherlock: Detecting Gene-Disease Associations by Matching Patterns of Expression QTL and GWAS
He, X., Fuller, C. K., Song, Y., Meng, Q., Zhang, B., Yang, X., & Li, H. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.03.022 · Cited by 241
The intestinal cholinergic anti-inflammatory pathway
Goverse, G., Stakenborg, M., & Matteoli, G. (2016) · The Journal of Physiology · doi:10.1113/jp271537 · Cited by 109
Metadata
- Authors
- Snoek, S. A., Verstege, M. I., van der Zanden, E. P., Deeks, N., Bulmer, D. C., Skynner, M., Lee, K., te Velde, A. A., Boeckxstaens, G. E., & de Jonge, W. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-04-26
- Volume
- 160
- Issue
- 2
- Pages
- 322-333
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2158445295
- Cited by
- 82
- References
- 12
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.00699.x
- The paper
- Snoek, S. A., Verstege, M. I., van der Zanden, E. P., Deeks, N., Bulmer, D. C., Skynner, M., Lee, K., te Velde, A. A., Boeckxstaens, G. E., & de Jonge, W. J. (2010). Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.00699.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.